Avdoralimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Avdoralimab, covering 2021-05-27 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody [Phase 2]